TIPE2: A Candidate for Targeting Antitumor Immunotherapy.
Luxia Xu,Feiyan Pan,Zhigang Guo
DOI: https://doi.org/10.4049/jimmunol.2300433
2024-01-01
The Journal of Immunology
Abstract:TNF-a-induced a- induced protein 8- like 2 (TIPE2 or TNFAIP8L2) is a recently discovered negative regulator of innate and adaptive immunity. TIPE2 is expressed in a wide range of tissues, both immune and nonimmune, and is implicated in the maintenance of immune homeostasis within the immune system. Furthermore, TIPE2 has been shown to play a pivotal role in the regulation of inflammation and the development of tumor. This review focuses on the structural characteristics, expression patterns, and functional roles of TIPE proteins, with a particular emphasis on the role and underlying mechanisms of TIPE2 in immune regulation and its involvement in different diseases. However, the current body of evidence is still limited in providing a comprehensive understanding of the complex role of TIPE2 in the human body, warranting further investigation to elucidate the possible mechanisms and functions of TIPE2 in diverse disease contexts. The 2024, 212: 755-763.- 763.
What problem does this paper attempt to address?